S00624 Summary:

Amd §2165, Pub Health L
Requires immunization of certain post-secondary students for COVID-19.
Go to top    

S00624 Actions:

Go to top

S00624 Committee Votes:

Go to top

S00624 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S00624 Text:

                STATE OF NEW YORK
                               2023-2024 Regular Sessions
                    IN SENATE
                                     January 5, 2023
        Introduced  by  Sen. HOYLMAN -- read twice and ordered printed, and when
          printed to be committed to the Committee on Health
        AN ACT to amend the public health law,  in  relation  to  requiring  the
          immunization of certain post-secondary students against COVID-19
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. Subdivision 1 of section 2165 of the public health law,  as
     2  added  by  chapter  405  of  the laws of 1989, paragraph b as amended by
     3  chapter 325 of the laws of 1991, and subdivision 13 is renumbered subdi-
     4  vision 12, is amended to read as follows:
     5    1. As used in this section, unless the context requires otherwise:
     6    a. The term "institution" means a college as defined in section two of
     7  the education law.
     8    b. The term "student" means any person born on or after January first,
     9  nineteen hundred fifty-seven, who is registered  to  attend  or  attends
    10  classes  at  an  institution, whether full-time or part-time. "Part-time
    11  student" shall mean a student who is enrolled for at least six but  less
    12  than  twelve  semester hours, or the equivalent per semester or at least
    13  four but less than eight semester hours per quarter at an institution.
    14    c. The term "health practitioner" means any person authorized  by  law
    15  to administer an immunization.
    16    d.  The  term  "immunization"  means  an  adequate dose or doses of an
    17  immunizing agent against measles, mumps [and],  rubella  and  the  novel
    18  coronavirus  (COVID-19) which meets the standards approved by the United
    19  States public health service for such biological products, and which  is
    20  approved  by the state department of health under such conditions as may
    21  be specified by the public health council.
    22    § 2. This act shall take effect on the thirtieth day  after  it  shall
    23  have become a law.
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
Go to top